HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCNAO National Center of Oncological Hadrontherapy
About this trial
The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results.
Eligibility criteria
Qualifiers
Patients with at least a follow up of 5 years with head and neck, skull base and brain tumors and no evidence of progressive disease.
The patient is able to give consent
Disqualifiers
Re-irradiation.
Second tumor.
Known cases of any psychiatric and neurological diseases leading to disability (eg, manic disorder, schizophrenia etc..), which could impair compilation of questionnaires or affect quality of life.
Histological and/or radiological diagnosis of head and neck tumors
Trial design
Treatments tested in this trial
- questionnaires administration
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov